Treatment Options for Cervical Dystonia
Botulinum toxin injections should be offered as the first-line treatment for cervical dystonia, with AboBoNT-A and rimaBoNT-B having the strongest evidence for efficacy. 1
First-Line Treatment: Botulinum Toxin
Botulinum Toxin Formulations
- All FDA-approved formulations of botulinum neurotoxin are commonly used to treat cervical dystonia, though with differing levels of evidence 1
- AboBoNT-A (Dysport) and rimaBoNT-B (Myobloc) have similar efficacy and should be offered as first-line options 1
- OnaBoNT-A (Botox) and incoBoNT-A (Xeomin) also have similar efficacy and should be considered as treatment options 1, 2
Mechanism and Benefits
- Botulinum toxin works by inhibiting acetylcholine release at nerve terminals, causing transient flaccid paralysis of affected muscles 2, 3
- Treatment benefits include:
Administration Considerations
- Treatment should be customized to individual muscle involvement patterns 2, 5
- EMG guidance may allow more precise injections and improve outcomes 3, 5
- Ultrasonography guidance can also enhance precision of injections 5
- Optimal dosing varies by formulation:
Treatment Response
- Approximately 79% of patients report subjective improvement 6
- Effects typically last 3-4 months, requiring periodic reinjections 2, 4
- Long-term efficacy has been demonstrated in patients treated for up to 20 years 4
Adjunctive Treatments
Rehabilitation Approaches
- Referral to rehabilitation specialists for comprehensive neuromusculoskeletal management 1
- Physical therapy may enhance the effects of botulinum toxin treatment 5
- Specific rehabilitation protocols can help improve outcomes, though standardized protocols are still needed 5
Pharmacological Options
- Nerve-stabilizing agents can be prescribed for pain management and spasm control:
Monitoring and Follow-up
Adverse Effects Management
- Common side effects include:
- Risk of adverse events increases with higher doses 6
- Experience and improved injection techniques can largely prevent adverse effects 2
Non-motor Symptoms
- Assessment and treatment of associated non-motor symptoms is crucial for optimal outcomes:
Special Considerations
Immunoresistance
- Primary and secondary immunoresistance due to neutralizing antibodies is relatively uncommon with newer formulations 5, 4
- Using the lowest effective dose at the longest possible interval may help maintain responsiveness 3
Treatment Failures
- Approximately 30% of patients discontinue treatment 5
- Factors contributing to treatment failure include:
Head and Neck Cancer Survivors
- Head and neck cancer survivors with cervical dystonia (which can be caused by neck dissection, radiation, or both) should be assessed and treated with the same approach 1